Journal: bioRxiv
Article Title: Neuroepithelial progenitors generate and propagate non-neuronal action potentials across the spinal cord
doi: 10.1101/2020.05.23.111955
Figure Lengend Snippet: Floor-plate biphasic action potentials are triggered by the activation of nicotinic acetylcholine receptors in response to acetylcholine released by motoneurons. a, Example of recurrent spontaneous floor-plate action potentials blocked after addition of the nicotinic acetylcholine receptor (nAChR) antagonists: Mecamylamine (50 μM) and d-Tubocurarine (5 μM). b, Example of current-clamp recording showing floor-plate action potential evoked by electrical stimulation in control condition (black trace) and after addition of the nAChR antagonists (red trace). c, Example of current-clamp recording showing floor-plate action potential evoked in control condition (black trace) and after addition of antagonists against ionotropic receptor for GABA (Gabazine 3 μM) and glutamate (DL-APV 200 μM and CNQX 20 μM). d, Example of current-clamp recording showing that floor-plate action potential can be evoked by local application of 30 μM acetylcholine (left trace), even in the presence of TTX (1 μM) and antagonists to AMPA/Kainate glutamate receptor (CNQX 10 μM), NMDA glutamate receptor (DL-APV 200 μM), GABA A receptor (Gabazine 3 μM) and glycine receptor (strychnine 1 μM) (center trace). Floor-plate action potential evoked by acetylcholine were blocked by the addition of nAChR antagonists (right trace). Note that the addition of TTX inhibited the fast component of the biphasic action potential (see Supplementary Figure 2 ). e, Confocal image of a coronal section from a ChAT:ChR2-YFP mouse embryo at E12.5 showing the expression of Channelrhodopsin2-YFP fusion protein (in green) in cholinergic motoneurons located in the ventro-dorsal horns and labelled with the vesicular acetylcholine transporter vAChT (in red). All cell nuclei were labelled using DAPI (in blue). f, Example of current-clamp recording from a ChAT:ChR2-YFP + motoneuron showing an action potential triggered by the opening of Channelrhodopsin 2 in response to blue light stimulation (470 nm). g, Example of current-clamp recording from a floor-plate cell recorded in a ChAT:ChR2-YFP + fetal spinal cord showing how blue light stimulation could evoke a slow cholinergic depolarization and trigger a biphasic action potential that were blocked by the addition of nAChR antagonists.
Article Snippet: The following pharmacological agents were used: Acetylcholine chloride (30 μM, Sigma-Aldrich, Germany), TTX (1 μM, Alomone Labs, Israel), gabazine (3 μM, Tocris, USA), CNQX Disodium (20 μM, Tocris, USA), DL-APV (200 μM, Tocris, USA), Mecamylamine hydrochloride (100 μM, Tocris, USA), D-turbocurarine chloride (10 μM,Tocris Bioscience, Minneapolis, MN, USA), 18-β glycyrrhetinic acid (50 μM, Sigma-Aldrich, Germany) and TTA-P2 (3μM, Alomone, Israel).
Techniques: Activation Assay, Expressing